Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
How do you counsel patients who are found to have a carrier mutation in a single high-risk APOL1 allele?
Related Questions
How do you manage oral prednisone when initiating nefecon in a patient with IgA nephropathy?
How does your approach to the differential diagnosis of membranous nephropathy change when PLA2R positivity is detected alongside a chronic viral infection such as HIV, HBV, or HCV?
How do various therapeutic approaches for IgA nephropathy target the different stages of the four-hit hypothesis?
How would you tailor immunosuppression in an elderly patient presenting with primary FSGS?
How do you decide when to stop immunosuppression in a patient with granulomatosis with polyangiitis who is on dialysis, has not yet recovered renal function, but has shown improvement in ANCA levels?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
Do you wait until serum anti-GBM antibody titers are undetectable before hospital discharge in a patient with anti-GBM antibody disease with renal involvement who is receiving daily plasmapheresis, cyclophosphamide, and steroids?
What is your approach to treating IgA nephropathy in patients who also have IgA vasculitis?
How do you manage nephrotic range proteinuria in a pregnant patient with a known history of diabetic nephropathy prior to pregnancy?
How would you treat idiopathic isolated renal TMA diagnosed on renal biopsy without evidence of MAHA?
